Incyte (INCY) Gets a Buy From Piper Sandler
TipRanks15:25 ET
Incyte Analyst Ratings
BenzingaApr 23 07:59 ET
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), BioMarin Pharmaceutical (BMRN) and ACADIA Pharmaceuticals (ACAD)
TipRanksApr 8 22:40 ET
Incyte Analyst Ratings
BenzingaMar 25 10:25 ET
RBC Capital Sticks to Its Hold Rating for Incyte (INCY)
TipRanksMar 24 21:48 ET
Analysts Are Bullish on Top Healthcare Stocks: Biote (BTMD), Incyte (INCY)
TipRanksMar 13 07:40 ET
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Incyte (INCY)
TipRanksMar 13 06:50 ET
Incyte's Hold Rating: Balancing Clinical Promise Against Financial and Market Position
TipRanksMar 13 00:25 ET
Incyte Analyst Ratings
BenzingaMar 12 11:13 ET
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), AnaptysBio (ANAB) and ITeos Therapeutics (ITOS)
TipRanksMar 12 06:40 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY), Fortrea Holdings Inc. (FTRE) and Abbott Labs (ABT)
TipRanksMar 12 05:20 ET
Incyte's Growth Potential Weighed Against Upcoming Challenges: A Hold Rating Analysis
TipRanksMar 11 07:08 ET
Analysts Offer Insights on Healthcare Companies: Incyte (INCY) and Insmed (INSM)
TipRanksMar 5 07:40 ET
Incyte Analyst Ratings
BenzingaFeb 23 05:52 ET
Analysts Conflicted on These Healthcare Names: Incyte (INCY), Gilead Sciences (GILD) and Shockwave Medical (SWAV)
TipRanksFeb 16 08:00 ET
Incyte Corporation: A Hold Recommendation Amidst Modest Growth and Pipeline Developments
TipRanksFeb 15 02:55 ET
Analysts Offer Insights on Healthcare Companies: Lantheus (LNTH), Incyte (INCY) and Fusion Pharmaceuticals (FUSN)
TipRanksFeb 15 01:20 ET
Incyte Downgraded Amid Missed Acquisition Opportunity
InvestingFeb 14 10:20 ET
Stifel Adjusts Price Target on Incyte to $68 From $67, Maintains Hold Rating
MT NewswiresFeb 14 09:38 ET
Incyte Analyst Ratings
BenzingaFeb 14 08:20 ET
No Data
No Data